A number of research firms have changed their ratings and price targets for Bicycle Therapeutics (NASDAQ: BCYC): 3/1/2023 – Bicycle Therapeutics had its price target lowered by analysts at Needham & Company LLC from $72.00 to $67.00. They now have a 'buy' rating on the stock. 3/1/2023 – Bicycle Therapeutics had its 'buy' rating reaffirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock. 2/28/2023 – Bicycle Therapeutics had its 'buy' rating reaffirmed by analysts at EF Hutton Acquisition Co.

https://www.dailypolitical.com/2023/03/08/analysts-recent-ratings-updates-for-bicycle-therapeutics-bcyc.html

#dailypolitical